Corifollitropin Alfa Versus Follitropin Beta in High Responders

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this randomized controlled trial (RCT) is to compare a single injection of corifollitropin-alfa versus daily injections of follitropin beta regarding the number of oocytes retrieved, hormonal profile and follicle development in patients with high response undergoing ovarian stimulation for in vitro fertilization treatment using a gonadotropin-releasing hormone (GnRH) antagonist protocol combined with GnRH agonist trigger and cryopreservation of all embryos.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Eugonia
• Treatments: Follicle Stimulating Hormone

Criteria

Inclusion Criteria:

• Age: 18-40 years

• Polycystic ovaries (PCO) or polycystic ovary syndrome (PCOS)

• no endometriotic cyst

Exclusion Criteria:

• Patients with poor response

• Patients using human chorionic gonadotropin (hCG) for triggering final oocyte maturation.